Mark Driscoll Ph.D. is the co-founder of Intus Biosciences and inventor of the Titan-1 technology behind the GutID microbiome test, which combines novel lysis, novel amplicon information space enabling substrain level bacterial resolution and database independence. This unique combination of features enables actionability from microbiome information for targets ranging from cancer to chronic disease to infectious disease. Previously, at 454 Life Sciences/Roche, Mark led the team that developed of the GS-20, the world’s first next-generation (NGS) sequencer, which revolutionized genetic research, diagnostics and the understanding of the microbiome.